Glucose oxidase mediated targeted cancer-starving therapy by biotinylated self-assembled vesicles

Soumik Dinda1, Saheli Sarkar, Prasanta Kumar Das

  • 1Department of Biological Chemistry, Indian Association for the Cultivation of Science, Kolkata - 700 032, India. bcpkd@iacs.res.in.

Chemical Communications (Cambridge, England)
|August 18, 2018
PubMed

Insights

This study introduces a novel cancer therapy using glucose oxidase (GOx) within self-assembled vesicles. These targeted vesicles starve cancer cells by blocking their energy supply, showing significantly higher efficiency against cancer cells.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Therapy

Background:

  • Cancer cells exhibit altered metabolism, relying heavily on glucose.
  • Targeted therapies aim to selectively eliminate cancer cells while sparing healthy ones.
  • Nanocarriers offer potential for drug delivery and therapeutic agent encapsulation.

Purpose of the Study:

  • To develop a targeted cancer-starving therapy using glucose oxidase (GOx).
  • To investigate the efficacy of self-assembled trimesic acid based biotinylated amphiphile (TMB) vesicles for cancer treatment.
  • To evaluate the selective killing of cancer cells by GOx-loaded TMB vesicles.

Main Methods:

  • Self-assembly of trimesic acid based biotinylated amphiphile (TMB) into vesicles.
  • Encapsulation of glucose oxidase (GOx) enzyme within TMB vesicles.
  • In vitro evaluation of cell viability using cancer cell lines (HeLa, B16F10) and non-cancer cell lines (CHO, NIH3T3).

Main Results:

  • TMB vesicles successfully entrapped GOx.
  • GOx-loaded TMB vesicles demonstrated selective toxicity towards cancer cells.
  • Cancer cells showed approximately 6-fold higher sensitivity to the therapy compared to non-cancer cells.
  • The mechanism involves blocking tumor energy supply via intracellular glucose oxidation.

Conclusions:

  • Self-assembled TMB vesicles loaded with GOx represent a promising strategy for targeted cancer-starving therapy.
  • This approach offers enhanced selectivity and efficiency in eliminating cancer cells.
  • The findings highlight the potential of nanovesicle-based enzyme delivery for cancer treatment.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

Overview
111.0K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
4.3K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.5K
Protein Complex Assembly02:41

Protein Complex Assembly

Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types.  Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...
16.8K